Clinical Trials Browser

Not yet recruiting × Lung Neoplasms × 30 days × Clear all

NCT07536178 2026-04-17

LoF

Phase NA Not yet recruiting

Asthma, Lung Neoplasms, Pulmonary Disease, Chronic Obstructive

NCT06538636 2026-04-16

PASI

Phase NA Not yet recruiting

23,520 enrolled

Lung Neoplasms

NCT07177846 2026-04-16

LiveWell: An Adapted Dialectical Behavioral Therapy Skills Training Protocol for Patients Living With Metastatic Lung Cancer

Phase NA Not yet recruiting

Lung Neoplasms

NCT07520799 2026-04-14

The Effect of Mindfulness-Based Breathing Exercises on Dyspnea, Symptom Control, and Quality of Life in Lung Cancer Patients Undergoing Chemotherapy

Phase NA Not yet recruiting

Lung Neoplasms

NCT06982222 2026-04-13

Testing the Safety of the Anti-cancer Drug, Sn-117m-DTPA, for Advanced Cancers That Have Spread to Bones

Phase 1 Not yet recruiting

BreastGenitourinaryThoracic

Breast Neoplasms, Carcinoma, Non-Small-Cell Lung, Lung Neoplasms, Prostatic Neoplasms

NCT07521618 2026-04-13

One-stop

Phase NA Not yet recruiting

Lung Neoplasms

NCT07524803 2026-04-13

LUCAS-LATAM

Not yet recruiting

Lung Neoplasms

NCT07519655 2026-04-09

Phase 1 Study of PF-08046033 in Advanced Solid Tumors

Phase 1 Not yet recruiting

DermatologicGastrointestinalThoracic

Esophageal Neoplasms, Lung Neoplasms, Melanoma

NCT06816979 2026-04-08

Lumbar Punctures for the Detection of ctDNA in the Cerebrospinal Fluid of Patients With Stage III and IV Non-Small Cell Lung Cancer

Phase NA Not yet recruiting

Carcinoma, Non-Small-Cell Lung, Lung Neoplasms

NCT07176000 2026-04-08

Tailored Patient Navigation to Improve the Uptake of Lung Cancer Screening in Tribal Communities in Western Washington State, SACRED LUNGS Trial

Phase NA Not yet recruiting

Lung Neoplasms

NCT07506889 2026-04-08

EXHALE-CO2

Not yet recruiting

Disease, Lung Neoplasms, Motor Activity

NCT07513818 2026-04-07

IMPULSION

Phase NA Not yet recruiting

20,000 enrolled

Lung Neoplasms, Smoking Cessation

NCT07500285 2026-03-31

Yittrium-90(Y-90) Fibroblast Activation Protein Inhibitor (FAPI) Therapy in Patients With Non-Small Cell Lung Cancer (Phase II)

Phase 2 Not yet recruiting

Carcinoma, Non-Small-Cell Lung, Lung Neoplasms

NCT06809946 2026-03-30

DEFLECT I

Phase 2 Not yet recruiting

Lung Neoplasms

NCT07169617 2026-03-30

Testing the SurVaxM Vaccine for Lung Cancer Prevention

Phase 2 Not yet recruiting

Lung Neoplasms

NCT07499986 2026-03-30

Respiratory Muscle Training in Patients Undergoing Lung Cancer Surgery

Phase NA Not yet recruiting

Lung Neoplasms

NCT07495098 2026-03-27

Phase 1B Trial of Intratumoral Cisplatin for Stage IV Lung Cancer

Phase 1 Not yet recruiting

Carcinoma, Non-Small-Cell Lung, Lung Neoplasms

NCT07492121 2026-03-25

GAPIMET

Phase 2 Not yet recruiting

DermatologicThoracic

Lung Neoplasms, Melanoma

NCT06943664 2026-03-24

Photoimmunotherapy With ASP-1929 and Cemiplimab for the Treatment of Refractory, Inoperable, and Metastatic Stage IIIB-IV Non-small Cell Lung Cancer

Phase 2 Not yet recruiting

Carcinoma, Non-Small-Cell Lung, Lung Neoplasms

NCT07486648 2026-03-24

Precision

Phase 1/2 Not yet recruiting

Carcinoma, Non-Small-Cell Lung, Lung Neoplasms

NCT07489391 2026-03-24

Concomitant Use of Radiotherapy and Integrated Exercise - Lung Cancer

Phase NA Not yet recruiting

Carcinoma, Non-Small-Cell Lung, Lung Neoplasms, Motor Activity

NCT07490860 2026-03-24

A Restorative Justice-Based Lung Cancer Screening Decision-Making Support Intervention Tailored for Black Individuals to Increase Lung Cancer Screening Among Black Community Members, RESTORE Trial

Phase NA Not yet recruiting

Lung Neoplasms

NCT07282444 2026-03-23

CORRECT

Phase NA Not yet recruiting

Lung Neoplasms

NCT07486817 2026-03-23

Beamion 44: A Study to Test How Well Zongertinib is Tolerated by People With Advanced Non-small Cell Lung Cancer With HER2 Mutations When Given in Combination With Chemotherapy With or Without Pembrolizumab

Phase 2 Not yet recruiting

Lung Neoplasms

NCT07489066 2026-03-23

Symbiotic-Lung-10: A Study to Learn About PF-08634404 Alone or in Combination in Early-stage or Locally Advanced NSCLC

Phase 2 Not yet recruiting

Carcinoma, Carcinoma, Non-Small-Cell Lung, Lung Diseases, Lung Neoplasms

NCT07482605 2026-03-20

Furmonertinib Plus Radiotherapy for EGFR+ NSCLC With Pleural Effusion

Phase 2 Not yet recruiting

Adenocarcinoma of Lung, Carcinoma, Non-Small-Cell Lung, Lung Neoplasms, Pleural Effusion, Malignant